Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Ipsen | Mind Blowing Facts

Global Market: European shares rise as oil slide boosts risk appetite

European shares rose as technology stocks led gains and falling oil prices eased inflation concerns. The STOXX 600 advanced 0.56%, while investors also tracked the upcoming Trump-Xi meeting.

The Economic Times · Sep 21

Amneal Launches Its Generic Lanreotide Immediately While the Brand Still Posts Nearly a Billion in US Sales

FDA cleared Amneal's generic lanreotide, and it launched immediately. Why more competition has not yet cut what patients pay for monthly injections.

Medical Daily · Sep 20

Pharma Exec To Plead Guilty In Insider Trading Case: Report

Dishant Gupta allegedly used his wife's brokerage account to make more than $262,000 in illegal profits.

International Business Times · Sep 11, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

3 A-Rated Pharma Stocks to Boost Your Bottom Line

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

StockNews.com · Apr 10, 2024

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 27, 2022

Why Epizyme Shares Are Soaring Today

Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement to be acquired by Ipsen.

Benzinga · Jun 27, 2022

Life sciences firm Ipsen creating 50 jobs at its North Wales operation

Ipsen is investing further at Wrexham with a new drug product manufacturing facility

Birmingham Post · Mar 2, 2022

Read news from The Economist, FT, and more,
with one subscription

4 Mid-Cap Pharmaceutical Stocks to Buy This Month

Despite supply chain disruptions and labor shortages, the pharma industry is well-positioned to continue growing due to the increasing medical needs of an aging population and advancements in treating chronic diseases. Therefore, amid current market volatility, we believe it could be wise to scoop up shares of quality mid-cap pharmaceutical…

StockNews.com · Feb 3, 2022

Coverage From

People

Donald Trump

214,360 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Taro Pharmaceutical Industries Ltd

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.